New SEC Form D filing
Immuno Cancer Biotherapeutics, Inc., 2026-10-15
A new SEC Form D private-offering notice from Canton, SD, an undisclosed offering target in Biotech. The source filing is one click away.
What this filing says
Immuno Cancer Biotherapeutics, Inc. Verified via SEC Form D
Filed 2026-10-15Filed to raise Undisclosed The filer declared an indefinite offering amount; we say so instead of inventing a number.First money in 2026-10-09Raised so far $75,000HQ (as filed) Canton, SDSector Biotech machine-classified from the filing aloneStage (inferred) Pre-seedCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 2 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Petro Fluid Dynamics LLC, 2026-10-01, Rapid City, SD
- Estuary Biotherapeutics, Inc., 2026-10-16, $103.7M, Menlo Park, CA
- Norman Retirement, LLC, 2026-09-10, $3.7M, Aberdeen, SD
- Immorta Bio, Inc., 2026-10-16, $5M, Miami Beach, FL
- Countach Medical Corp, 2026-06-05, $750K, Sioux Falls, SD
- J3 BIOSCIENCE, INC., 2026-10-16, $50K, Salt Lake City, UT
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.